Abstract
Patients with renal or bladder cancers exhibit a unique association with adenovirus (Ad) infections. About 60% of them contain antibodies to Ad early antigens Both in their tumour cells and peripheral blood lymphocytes (PBL) they have detectable early Ad antigens known to be involved in malignant cell transformation. Transfection of tumour cell extracts resulted in complementing temperature-sensitive (ts) Ad mutants at nonpermissive temperatures (39 °C) indicating that some cells of the tumour mass possess active functions for Ad. Only 4 to 18% of control subjects were positive in these tests. Here we studied whether lymphocytes might be involved in tumourigenesis by Ad. PBL extracts of patients were transfected into HEp-2 culture cells, which were subsequently superinfected with Ad-5ts 18 andts19 mutants at 39°C. Titration of virus yields indicated complementation in 76% of patients with renal and bladder cancers in contrast to 20% of control individuals. Complementing ability of lymphocytes which had been prestimulated with phytohaemagglutinin (PHA) approached that of tumour extracts. It means that both specimens contain advanced functions in contrast to resting lymphocytes. Lymphocytes are nonpermissive for latently carried Ad infections. Expression, possible transfer of early Ad gene products via frequent contacts with tissue cells can result in removal of tumour suppressor gene products from complexes regulating cell cycle negatively. Further interaction with hormone-sensitive protooncogenes explains tissue, age and gender specificity of urological malignancies. These phenomena suggest an important cofactorial role for Ad in kidney and bladder tumours.
Similar content being viewed by others
References
Braithwaite, A., Nelson, C., Skulimowski, A., McGovern, J., Pigott, D., Jenkins, J.: Transactivation of the p53 oncogene by Ela gene products.Virology, 177, 595 (1990).
Csata, S., Kulcsár, G., Dán, P., Nász, I., Verebélyi, A.: Latent virus carrying lymphocytes of patients with urological tumours.Acta Chir. Hung., 28, 321 (1987).
Csata, S., Kulcsár, G., Horváth, J., Nász, I., Ongrádi, J., Verebélyi, A.: Study of antibodies to adenoviruses in patients with tumours of the urogenital system.Int. Urol. Nephrol., 14, 115 (1982).
Deb, S., Jackson, C. T., Subler, M. A., Martin, D. W.: Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.J. Virol., 66, 6164 (1992).
Dumont, D. J., Marcellus, R. C., Bayley, S. T., Branton, P. E.: Role of phosphorylation near the amino terminus of adenovirus type 5 early region 1A proteins.J. Gen. Virol., 74, 583 (1993).
Dyson, N., Guida, P., Münger, K., Harlow, E.: Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins.J. Virol., 66, 6893 (1992).
Elgavish, A.: Effects ofEscherichia coli andE. coli lipopolysaccharides on the function of human ureteral epithelial cell cultures in serum-free medium.Infect. Immun., 61, 3304 (1993).
Ewen, M. E., Faha, B., Harlow, E., Livingston, D. M.: Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.Science, 255, 85 (1992).
Faha, B., Ewen, M. E., Tsai, L.-H., Livingston, D. M., Harlow, E.: Interaction between human cyclin A and adenovirus E1A-associated p107 protein.Science, 255, 87 (1992).
Forslund, O., Hansson, B. G., Rymak, P., Bjerre, B.: Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples.J. Clin. Microbiol., 31, 1975 (1993).
Goodrich, D. W., Lee, W.-H.: Abrogation by c-myc of G1 phase arrest induced byRb protein but not by p53.Nature 360, 177 (1992).
Graham, F. L., van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA.Virology, 52, 456 (1973).
Gunthert, U., Hofman, M., Rudy, W.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.Cell, 65, 13 (1991).
Hagemeier, C., Bannister, A. J., Cook, A., Kouzarides, T.: The activation domain of transcription factor PU. 1 binds the retinoblastoma (RB) protein and the transcription factor TFIIDin vitro: RB shows sequence similarity to TFIID and TFIIB.Proc. Natl. Acad. Sci. USA, 90, 1580 (1993).
Halpern, B., Ky, N. T., Lagrue, G., Amache, N.: Le test aux lymphocytes en allergologie.Méd. et Hyg., 25, 55 (1967).
Hart, I. R., Saini, A.: Biology of tumour metastasis.Lancet, 339, 1453 (1992).
Hawker, K. L., Pintzas, A., Hennigan, R. F., Gillespie, D. A. F., Ozanne, B. W.: Transformation by thefos andjun oncogene does not increase AP-1 DNA-binding activity.J. Virol., 67, 5487 (1993).
Hoffman, P., Rajakumar, P., Hoffman, B., Heuerts, R., Wold, W. S. M., Carlin, C. R.: Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism.J. Virol., 66, 197 (1992).
Horváth, J., Faxing, C., Weber, J. M.: Complementation of adenovirus early region 1a and 2a mutants by Epstein-Barr virus immortalized lymphoblastoid cell lines.Virology, 184, 141 (1991).
Horwitz, M. S.: Adenoviridae and their replication. In: Fields, B. N., Knipe, D. M. (eds): Virology, 2nd ed. Raven Press, New York 1990, p. 1679.
Horwitz, M. S.: Adenoviruses. In: Fields, B. N., Knipe, D. M. (eds): Virology, 2nd ed. Raven Press, New York 1990, p. 1723.
Ibelgaufts, H., Jones, K. W., Maitland, N., Shaw, N. F.: Adenovirus-related RNA sequences in human neurogenic tumors.Acta Neuropathol. (Berlin), 56, 113 (1982).
Javier, R., Raska, K., Shenk, T.: Requirement for the adenovirus type 9E4 region in production of mammary tumors.Science, 257, 1267 (1992).
Kannabiran, C., Morris, G. F., Labrie, C., Mathews, M. B.: The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter.J. Virol., 67, 507 (1993).
Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., Vogelstein, B.: Oncogenic forms of p53 inhibit p53-regulated gene expression.Science, 256, 827 (1992).
Kim, S.-J., Wagner, S., Liu, F., O’Reilly, M. A., Robbins, P. D., Green, M. R.: Retinoblastoma gene product activates expression of the humanTGF-β2 gene through transcription factor ATF-2.Nature, 358, 331 (1992).
Körner, H. Fritzsche, U., Burgert, H.-G.: Tumor necrosis factor α stimulates expression of adenovirus early region 3 proteins: Implications for viral persistence.Proc. Natl. Acad. Sci. USA 89, 11857 (1992).
Kulcsár, G., Csata, S., Nász, I.: Isolation of an infectious oncogenic adenovirus strain from the stimulated lymphocytes of a patient with bladder tumour.Acta Microbiol. Hung., 38, 91 (1991).
Kulcsár, G., Dán, P., Csata, S., Horváth, J., Nász, I., Verebélyi, A., Ongrádi, J.: Virological studies of malignant tumours of the urogenital system.Acta Microbiol. Hung., 30, 199 (1983).
Kurnick, J. T., Kradin, R. L., Blumberg, R., Schneeberger, E. E., Boyle, L. A.: Functional characterization of T lymphocytes propagated from human lung carcinomas.Clin. Immunol. Immunopathol., 38, 367 (1986).
Lane, D. P.: p53, guardian of the genome.Nature, 358, 15 (1992).
Latchman, D. S.: Transcriptional regulation of viral gene expression.Rev. Med. Virol., 3, 115 (1993).
Levine, A. J.: The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses.Virology, 177, 419 (1990).
Mizoguchi, H., O’Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., Ochoa, A. C.: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.Science, 258, 1795 (1992).
Nevins, J. R.: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins.Science, 258, 424 (1992).
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., Vogelstein, B.: Mutations in thep53 gene occur in diverse human tumour types.Nature, 342, 705 (1989).
Ongrádi, J.: Characterization of virus mutants and their use in the study on biology of viruses (in Hungarian).Biológia, 33, 13 (1985).
Ongrádi, J., Bertók, L., Farkas, J., Nász, I., Bendinelli, M.: Endotoxins and prednisolone alter replication of type 5 adenovirus and its temperature-sensitive mutants.Acta Microbiol. Hung. (in press).
Ongrádi, J., Farkas, J., Csata, S.: Complementability of temperature-sensitive adenovirus mutants with extracts of urogenital tumour cells.Acta Microbiol. Hung., 34, 187 (1987).
Ongrádi, J., Farkas, J., Kulcsár, G., Vámos, R., Horváth, J., Sokolova, T. M., Nász, I., Bendinelli, M.: Suppressed phagocytosis but promoted bacterial growth upon the effect of virus free supernatants of infected lymphocytes.Acta Microbiol. Hung. (in press).
Ongrádi, J., Kulcsár, G., Bertók, L.: Toxicity of microbial products in cell culture.Folia Microbiol., 29, 450 (1984).
Ongrádi, J., Telekes, A., Farkas, J., Nász, I., Bendinelli, M.: The effect of prostaglandins on the replication of adenovirus wild types and temperature-sensitive mutants.Acta Microbiol. Hung. (in press).
Radeke, H. H., Schwinzer, B., Resch, K.: Activated T-lymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells.Clin. Exp. Immunol., 90, 483 (1992).
Rüther, U., Nunnensiek, C., Müller, H. A. G., Rupp, W., Bader, H., Jipp, P.: Evidence of EBV DNA and adenovirus 2 E1A (types 2 and 5) in the mucous membrane of bronchial carcinoma and pleuramesothelioma. In: International Congress of Virology, Glasgow, Scotland, 8–13 August, 1993. Abstracts, p. 310.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J., Shenk, T.: Wild type p53 binds to the TATA-binding protein and represses transcription.Proc. Natl. Acad. Sci. USA, 89, 12028 (1992).
Shepherd, S. E., Howe, J. A., Mymryk, J. S., Bayley, S. T.: Induction of the cell cycle in baby rat kidney cells by adenovirus type 5 E1A in the absence of E1B and possible influence of p53.J. Virol., 67, 2944 (1993).
Soddu, Lewis, A. M. Jr.: Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.J. Virol., 66, 2875 (1992).
Straight, S. W., Hinkle, P. M., Jewers, R. J., McCance, D. J.: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.J. Virol., 67, 4521 (1993).
Sugimura, T.: Multistep carcinogenesis: A 1992 perspective.Science, 258, 603 (1992).
Taródi, B., Blair, G. E., Rekosh, D. M., Russell, W. C.: Characterization of two temperature-sensitive mutants of adenovirus type 5.J. Gen. Virol., 43, 531 (1979).
Walker, C., Goldsworthy, Wolf, D. C., Everitt, J.: Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene.Science, 255, 1693 (1993).
Weber, J. M., Anderson, C. W.: Identification of the gene coding for the precursor of adenovirus core protein X.J. Virol., 62, 1741 (1988).
Whitley, R. J.: Herpes simplex viruses. In: Fields, B. N., Knipe, D. M. (eds): Virology, 2nd ed. Raven Press, New York 1990, p. 1843.
Wigler, M., Pellicer, A., Silverstein, S., Axel, R.: Biochemical transfer of single-copy eukaryotic genes using total cellular DNA as donor.Cell, 14, 725 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ongrádi, J., Csata, S., Farkas, J. et al. Transfected lymphocyte extracts of patients with urological tumours: Complement temperature-sensitive adenovirus mutantsin vitro . International Urology and Nephrology 26, 361–373 (1994). https://doi.org/10.1007/BF02768003
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02768003